Hillman Capital Management, Inc.: ZIMMER BIOMET HOLDINGS INC (ZBH): Quarterly 13F Position History
As of Q2 2026, Hillman Capital Management, Inc. reported 53,943 shares of ZIMMER BIOMET HOLDINGS INC (ZBH), worth $4.6M and representing 3.4% of its 13F equity book. Quarter-over-quarter share count change: 1,757 (-3.2%) . The position first appeared in Q3 2021 and has been disclosed across 20 13F-HR filings in Pactolio's tracked window.
- 53,943Shares Held (Latest Filing)
- $4.6MReported Market Value (Latest Filing)
- 3.4%Portfolio Weight (% of 13F Equity Book)
- 1,757Quarter-over-Quarter Share Change
- -$392.4KQuarter-over-Quarter Value Change
- 80,687Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 20 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 53,943 | 1,757 | -3.2% | $4.6M | 3.4% | $86.1 |
| Q1 2026 | 55,700 | +9,731 | +21.2% | $5.0M | 3.5% | $90.4 |
| Q4 2025 | 45,969 | 6,846 | -13.0% | $4.1M | 2.6% | $89.9 |
| Q3 2025 | 52,815 | 2,783 | -5.0% | $5.2M | 3.0% | $98.5 |
| Q2 2025 | 55,598 | 2,959 | -5.1% | $5.1M | 2.8% | $91.2 |
| Q1 2025 | 58,557 | 20,382 | -25.8% | $6.6M | 3.3% | $113.2 |
| Q4 2024 | 78,939 | 1,748 | -2.2% | $8.3M | 3.1% | $105.6 |
| Q3 2024 | 80,687 | +34,389 | +74.3% | $8.7M | 3.0% | $108.0 |
| Q2 2024 | 46,298 | 146 | -0.3% | $5.0M | 1.8% | $108.5 |
| Q1 2024 | 46,444 | +960 | +2.1% | $6.1M | 2.0% | $132.0 |
| Q4 2023 | 45,484 | 972 | -2.1% | $5.5M | 1.9% | $121.7 |
| Q3 2023 | 46,456 | 1,810 | -3.8% | $5.2M | 2.0% | $112.2 |
| Q2 2023 | 48,266 | 140 | -0.3% | $7.0M | 2.5% | $145.6 |
| Q1 2023 | 48,406 | 190 | -0.4% | $6.3M | 2.4% | $129.2 |
| Q4 2022 | 48,596 | 10,302 | -17.5% | $6.2M | 2.4% | $127.5 |
| Q3 2022 | 58,898 | +390 | +0.7% | $6.2M | 2.6% | $104.5 |
| Q2 2022 | 58,508 | +6,207 | +11.9% | $6.1M | 2.2% | $105.1 |
| Q1 2022 | 52,301 | +813 | +1.6% | $6.7M | 2.1% | $127.9 |
| Q4 2021 | 51,488 | +47,689 | +1255.3% | $6.5M | 2.2% | $127.0 |
| Q3 2021 | 3,799 | – | – | $556.0K | 0.2% | $146.4 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Hillman Capital Management, Inc. first disclose a ZBH position in 13F-HR filings?
Hillman Capital Management, Inc. first reported ZIMMER BIOMET HOLDINGS INC (ZBH) on its 13F-HR filing for the period ending 2021-09-30 (Q3 2021). The position has appeared on 20 reported quarters within Pactolio's tracked window.
What was Hillman Capital Management, Inc.'s most recent quarter-over-quarter share-count change in ZBH?
Between Q1 2026 and Q2 2026, Hillman Capital Management, Inc. reduced its ZBH position by 1,757 shares (-3.2%), leaving 53,943 shares at a market value of $4.6M.
Does the implied price-per-share represent Hillman Capital Management, Inc.'s cost basis in ZBH?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.